Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Jelle Demeestere - , Universitair Ziekenhuis (UZ) Leuven (Autor:in)
  • Muhammad M Qureshi - , Boston Medical Center (BMC) (Autor:in)
  • Lieselotte Vandewalle - , Universitair Ziekenhuis (UZ) Leuven (Autor:in)
  • Anke Wouters - , Universitair Ziekenhuis (UZ) Leuven (Autor:in)
  • Daniel Strbian - , University of Helsinki (Autor:in)
  • Raul G Nogueira - , Grady Health System (Autor:in)
  • Simon Nagel - , Klinikum Ludwigshafen (Autor:in)
  • Hiroshi Yamagami - , Osaka National Hospital (Autor:in)
  • Volker Puetz - , Klinik und Poliklinik für Neurologie, Dresdner NeurovaskuläresCentrum (Autor:in)
  • Mohamad Abdalkader - , Boston Medical Center (BMC) (Autor:in)
  • Diogo C Haussen - , Grady Health System (Autor:in)
  • Mahmoud H Mohammaden - , Grady Health System (Autor:in)
  • Markus A Möhlenbruch - , Universitätsklinikum Heidelberg (Autor:in)
  • Marta Olivé-Gadea - , Hospital Universitari Vall d'Hebron (Autor:in)
  • Simon Winzer - , Dresdner NeurovaskuläresCentrum, Klinik und Poliklinik für Neurologie (Autor:in)
  • Marc Ribo - , Hospital Universitari Vall d'Hebron (Autor:in)
  • Patrik Michel - , Centre Hospitalier Universitaire Vaudois (Autor:in)
  • João Pedro Marto - , Centro Hospitalar Lisboa West E.P.E. (CHLO) (Autor:in)
  • Kanta Tanaka - , National Cerebral and Cardiovascular Center (Autor:in)
  • Shinichi Yoshimura - , Hyogo Medical University (Autor:in)
  • Nicolas Martinez-Majander - , University of Helsinki (Autor:in)
  • Francois Caparros - , Université de Lille (Autor:in)
  • Hilde Henon - , Université de Lille (Autor:in)
  • Liisa Tomppo - , University of Helsinki (Autor:in)
  • Anne Dusart - , CHU de Charleroi (Autor:in)
  • Flavio Bellante - , CHU de Charleroi (Autor:in)
  • João Nuno Ramos - , Centro Hospitalar Lisboa West E.P.E. (CHLO) (Autor:in)
  • Jessica Jesser - , Universitätsklinikum Heidelberg (Autor:in)
  • Sunil A Sheth - , University of Texas Health Science Center at Houston (Autor:in)
  • Santiago Ortega-Gutiérrez - , University of Iowa (Autor:in)
  • James E Siegler - , The University of Chicago (Autor:in)
  • Stefania Nannoni - , University of Cambridge (Autor:in)
  • Johannes Kaesmacher - , Inselspital - Universitätsspital Bern (Autor:in)
  • Tomas Dobrocky - , Inselspital - Universitätsspital Bern (Autor:in)
  • Sergio Salazar-Marioni - , University of Texas Health Science Center at Houston (Autor:in)
  • Mudassir Farooqui - , University of Iowa (Autor:in)
  • Pekka Virtanen - , University of Helsinki (Autor:in)
  • Rita Ventura - , Centro Hospitalar Lisboa West E.P.E. (CHLO) (Autor:in)
  • Syed F Zaidi - , University of Toledo (Autor:in)
  • Alicia C Castonguay - , University of Toledo (Autor:in)
  • Kazutaka Uchida - , Hyogo Medical University (Autor:in)
  • Ajit S Puri - , University of Massachusetts Medical School (Autor:in)
  • Nobuyuki Sakai - , Kobe City Hospital Organization (Autor:in)
  • Kazunori Toyoda - , National Cerebral and Cardiovascular Center (Autor:in)
  • Behzad Farzin - , Centre Hospitalier de l'Université de Montreal (CHUM) (Autor:in)
  • Hesham E Masoud - , State University of New York at Albany (Autor:in)
  • Piers Klein - , Boston Medical Center (BMC) (Autor:in)
  • Jenny Bui - , Boston Medical Center (BMC) (Autor:in)
  • Federica Rizzo - , Hospital Universitari Vall d'Hebron (Autor:in)
  • Daniel P O Kaiser - , Dresdner NeurovaskuläresCentrum, Institut und Poliklinik für Diagnostische und Interventionelle Neuroradiologie (Autor:in)
  • Philippe Desfontaines - , University of Liege (Autor:in)
  • Davide Strambo - , Centre Hospitalier Universitaire Vaudois (Autor:in)
  • Charlotte Cordonnier - , Université de Lille (Autor:in)
  • Eugene Lin - , Mercy Health, Ohio (Autor:in)
  • Peter A Ringleb - , Universitätsklinikum Heidelberg (Autor:in)
  • Daniel Roy - , Centre Hospitalier de l'Université de Montreal (CHUM) (Autor:in)
  • Osama O Zaidat - , Mercy Health, Ohio (Autor:in)
  • Urs Fischer - , Universitätsspital Basel (Autor:in)
  • Jean Raymond - , Centre Hospitalier de l'Université de Montreal (CHUM) (Autor:in)
  • Robin Lemmens - , Universitair Ziekenhuis (UZ) Leuven (Autor:in)
  • Thanh N Nguyen - , Boston Medical Center (BMC) (Autor:in)

Abstract

BACKGROUND: Studies comparing bridging intravenous thrombolysis (IVT) with direct endovascular therapy (EVT) in patients with acute ischemic stroke who present late are limited. We aimed to compare the clinical outcomes and safety of bridging IVT in patients with acute ischemic stroke due to anterior circulation large vessel occlusion who underwent EVT 6 to 24 hours after time last known well.

METHODS: We enrolled patients with anterior circulation large vessel occlusion stroke and a National Institutes of Health Stroke Scale score of ≥6 from 20 centers across 10 countries in the multicenter retrospective CLEAR study (CT for Late Endovascular Reperfusion) between January 2014 and May 2022. We used inverse probability of treatment weighting modeling adjusted for clinical and imaging confounders to compare functional outcomes, reperfusion success, symptomatic intracranial hemorrhage, and mortality between EVT patients with and without prior IVT.

RESULTS: Of 5098 patients screened for eligibility, we included 2749 patients, of whom 549 received bridging IVT before EVT. The timing of IVT was not recorded. Witnessed stroke onset and transfer rates were higher in the bridging IVT group (25% versus 12% and 77% versus 55%, respectively, P value for both <0.0001), and time intervals between stroke onset and treatment were shorter (time last known well-start of EVT median 560 minutes [interquartile range, 432-791] versus 724 minutes [interquartile range, 544-912]; P<0.0001). After adjustment for confounders, there was no difference in functional outcome at 3 months (adjusted common odds ratio for modified Rankin Scale shift, 1.03 [95% CI, 0.89-1.19]; P=0.72) or successful reperfusion (adjusted odds ratio, 1.19 [95% CI, 0.81-1.75]; P=0.39). There were no safety concerns associated with bridging IVT versus direct EVT (symptomatic intracranial hemorrhage: adjusted odds ratio, 0.75 [95% CI, 0.38-1.48]; P=0.40; mortality: adjusted odds ratio, 1.14 [95% CI, 0.89-1.46]; P=0.31). Results were unchanged when the analysis was limited to patients who received IVT >6 hours after last known well.

CONCLUSIONS: In patients with an anterior circulation large vessel occlusion stroke who underwent EVT 6 to 24 hours from last known well, bridging IVT was not associated with a difference in outcomes compared with direct EVT.

REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04096248.

Details

OriginalspracheEnglisch
Seiten (von - bis)1767-1775
Seitenumfang9
FachzeitschriftStroke
Jahrgang55
Ausgabenummer7
Frühes Online-Datum15 Mai 2024
PublikationsstatusVeröffentlicht - Juli 2024
Peer-Review-StatusJa

Externe IDs

ORCID /0000-0001-5258-0025/work/160049697
Mendeley 9d32e692-a163-3035-8156-bd79ba3d6c6f
Scopus 85196512623

Schlagworte

Schlagwörter

  • Aged, Aged, 80 and over, Brain Ischemia/drug therapy, Endovascular Procedures/methods, Female, Fibrinolytic Agents/therapeutic use, Humans, Ischemic Stroke/therapy, Male, Middle Aged, Retrospective Studies, Thrombolytic Therapy/methods, Time-to-Treatment, Treatment Outcome